Parkinson's Disease is the fastest growing neurodegenerative disease in the world and has no cure. Patients progressively deteriorate across motor and non-motor domains with a significant incidence of institutional care. However, many potential pathophysiological targets have been identified and there is a recognised prodromal phase, which in combination with novel biological markers might allow the use of neuroprotective strategies at the earliest stages of disease.
This presentation will focus on our current disease modifying strategies and will also cover how we might find novel approaches for symptoms that lead to the loss of independence.
Simon Lewis is a Consultant Neurologist, an NHMRC Leadership Fellow and Professor of Cognitive Neurology at Macquarie University.
He has published over 300 peer review papers, 2 books and 8 book chapters and has helped to attract over $40 Million in funding from various sources including the NHMRC, MRFF, ARC and Michael J Fox Foundation to support his research targeting Parkinson’s Disease, Dementia with Lewy Bodies and related conditions.
For more details about the series, contact us at fmhhs.executive.dean@mq.edu.au.
Acknowledgement of Country
We acknowledge the Traditional Custodians of the land on which Macquarie University stands - the Wallumattagal Clan of the Dharug Nation - whose cultures and customs have nurtured, and continue to nurture, this land since time immemorial. We pay our respects to the Elders, past and present.
© Macquarie University | CRICOS Provider 000002J | Privacy | Getting here | Contact Us